Skip to content

Transforming the patient pathway through a cross-sectoral, short-stay hospital model focused on general medicine (STATAMED) - Substudy claims data analysis

Transforming the patient pathway through a cross-sectoral, short-stay hospital model focused on general medicine (STATAMED) - Substudy claims data analysis - STATAMED

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033096
Enrollment
2076
Registered
2023-11-27
Start date
2024-04-22
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients are eligible if they have: health insurance from one of the participating statutory health insurers, a general medical condition and inpatient treatment needs according to the criteria of the German Appropriate Evaluation Protocol (G-AEP), a diagnosis according to a project-specific ICD-10 code, and a foreseeable uncomplicated course of disease (Patient Clinical Complexity Level(PCCL) 0-2). The subsequent list of ICD-10 codes comprises exemplary diagnoses and is not exhaustive: I10.01 (

Interventions

Group 1: Treatment at a STATAMED site, including a pre-admission interview to determine a patient’s eligibility, followed by the formulation of a treatment plan if eligibility is confirmed, multidisci

Sponsors

AOK Rheinland/Hamburg – Die Gesundheitskasse
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients are eligible if they have: health insurance from one of the participating statutory health insurers, a general medical condition and inpatient treatment needs according to the criteria of the German Appropriate Evaluation Protocol (G-AEP), a diagnosis according to a project-specific ICD-10 code, and a foreseeable uncomplicated course of disease (Patient Clinical Complexity Level(PCCL) 0-2). The subsequent list of ICD-10 codes comprises exemplary diagnoses and is not exhaustive: I10.01 (Benign essential hypertension: With mention of hypertensive urgency), I48.1 (Persistent atrial fibrillation), E86 (Volume depletion), K59.09 (Other and unspecified constipation), I50.14 (Left ventricular failure: With symptoms at rest), I20.8 (Other forms of angina pectoris), I48.0 (Paroxysmal atrial fibrillation), R55 (Syncope and collapse), R07.3 (Other chest pain), K29.6 (Other gastritis), N39.0 (Urinary tract infection, site not specified), I50.13 (Left ventricular failure: With symptoms under mild strain), J20.9 (Acute bronchitis, unspecified), J18.9 (Pneumonia, unspecified), I50.01 (Secondary congestive heart failure), K57.32 (Diverticulitis of large intestine without perforation, abscess or bleeding), E11.91(Type 2 diabetes mellitus: Without complications, Uncontrolled), R10.3 (Pain localized to other parts of lower abdomen), A09.9 (Gastroenteritis and colitis of unspecified origin), K29.1 (Other acute gastritis).

Exclusion criteria

Exclusion criteria: Exclusion criteria are: highly technical diagnostic needs, the need for inpatient surgery, or transfers from other hospitals.

Design outcomes

Primary

MeasureTime frame
Combined primary outcome: hospital re-admission rate (within 30 days post-discharge) and length of hospital stay

Secondary

MeasureTime frame
Utilisation of ambulatory care services Utilisation of ambulatory care emergency services Utilisation of hospital emergency department Cost (ambulatory care, inpatient care, pharmaceuticals, medical and assistive devices, rehabilitation, and prospective actual cost of the intervention) Post-hospital care (especially the location of post-hospital care, such as at home or in a nursing care facility)

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026